rs3008

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000215.4(JAK3):​c.*123T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.488 in 1,054,640 control chromosomes in the GnomAD database, including 126,994 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 21277 hom., cov: 31)
Exomes 𝑓: 0.48 ( 105717 hom. )

Consequence

JAK3
NM_000215.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.568

Publications

29 publications found
Variant links:
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
JAK3 Gene-Disease associations (from GenCC):
  • T-B+ severe combined immunodeficiency due to JAK3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 19-17826620-A-G is Benign according to our data. Variant chr19-17826620-A-G is described in ClinVar as Benign. ClinVar VariationId is 328495.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.628 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JAK3NM_000215.4 linkc.*123T>C 3_prime_UTR_variant Exon 24 of 24 ENST00000458235.7 NP_000206.2 P52333-1A0A024R7M7
JAK3NM_001440439.1 linkc.*123T>C 3_prime_UTR_variant Exon 24 of 24 NP_001427368.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JAK3ENST00000458235.7 linkc.*123T>C 3_prime_UTR_variant Exon 24 of 24 5 NM_000215.4 ENSP00000391676.1 P52333-1

Frequencies

GnomAD3 genomes
AF:
0.522
AC:
79281
AN:
151812
Hom.:
21246
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.634
Gnomad AMI
AF:
0.445
Gnomad AMR
AF:
0.529
Gnomad ASJ
AF:
0.504
Gnomad EAS
AF:
0.453
Gnomad SAS
AF:
0.477
Gnomad FIN
AF:
0.509
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.466
Gnomad OTH
AF:
0.522
GnomAD4 exome
AF:
0.482
AC:
435176
AN:
902710
Hom.:
105717
Cov.:
12
AF XY:
0.480
AC XY:
226447
AN XY:
471464
show subpopulations
African (AFR)
AF:
0.643
AC:
14619
AN:
22742
American (AMR)
AF:
0.591
AC:
25584
AN:
43262
Ashkenazi Jewish (ASJ)
AF:
0.502
AC:
11369
AN:
22650
East Asian (EAS)
AF:
0.451
AC:
16734
AN:
37098
South Asian (SAS)
AF:
0.484
AC:
36009
AN:
74474
European-Finnish (FIN)
AF:
0.519
AC:
26295
AN:
50640
Middle Eastern (MID)
AF:
0.516
AC:
2331
AN:
4516
European-Non Finnish (NFE)
AF:
0.465
AC:
281531
AN:
605272
Other (OTH)
AF:
0.492
AC:
20704
AN:
42056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
12835
25670
38505
51340
64175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5882
11764
17646
23528
29410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.522
AC:
79369
AN:
151930
Hom.:
21277
Cov.:
31
AF XY:
0.523
AC XY:
38831
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.634
AC:
26267
AN:
41434
American (AMR)
AF:
0.530
AC:
8071
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.504
AC:
1748
AN:
3470
East Asian (EAS)
AF:
0.452
AC:
2330
AN:
5152
South Asian (SAS)
AF:
0.477
AC:
2299
AN:
4822
European-Finnish (FIN)
AF:
0.509
AC:
5375
AN:
10562
Middle Eastern (MID)
AF:
0.446
AC:
131
AN:
294
European-Non Finnish (NFE)
AF:
0.466
AC:
31646
AN:
67944
Other (OTH)
AF:
0.521
AC:
1100
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1920
3840
5759
7679
9599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
692
1384
2076
2768
3460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.505
Hom.:
23177
Bravo
AF:
0.531
Asia WGS
AF:
0.498
AC:
1732
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 20% of patients studied by a panel of primary immunodeficiencies. Number of patients: 18. Only high quality variants are reported. -

T-B+ severe combined immunodeficiency due to JAK3 deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
3.0
DANN
Benign
0.84
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3008; hg19: chr19-17937429; COSMIC: COSV71687290; COSMIC: COSV71687290; API